Anti-TRAPPC2B antibodies are used in the immunodetection of the protein trafficking protein particle complex subunit 2B. In humans, the canonical protein has a reported length of 140 amino acid residues and a mass of 16.4 kDa. Its subcellular localization is in the nucleus, ER, and cytoplasm. It is reported to be expressed in the brain, heart, kidney, liver, lung, pancreas, placenta, skeletal muscle, fetal cartilage, fibroblasts, placenta and lymphocytes. A member of the TRAPP small subunits protein family, TRAPPC2B is known to be involved with Golgi transport and the regulation of gene expression. Synonyms for this target antigen include SEDLP, SEDLP1, TRAPPC2P1, MBP-1 interacting protein-2A, spondyloepiphyseal dysplasia, late, pseudogene, and MIP-2A. Indicated applications for TRAPPC2B antibodies listed below include ELISA, Western Blot, Immunocytochemistry, and Immunohistochemistry.